Li Kang Biomedical Co., Ltd. (TPEX:6242)
Taiwan · Delayed Price · Currency is TWD 34.00
0.00 (0.00%)
Aug 19, 2026, 10:55 AM CST
Li Kang Biomedical Market Cap
Li Kang Biomedical has a market cap or net worth of 1.08 billion as of August 18, 2026. Its market cap has decreased by -19.81% in one year.
Market Cap
1.08B
Enterprise Value
1.03B
Revenue
573.36M
Ranking
n/a
PE Ratio
14.28
Stock Price
34.00
ChartMarket Cap Chart
Since May 2, 2006, Li Kang Biomedical's market cap has increased from 198.14M to 1.08B, an increase of 445.78%. That is a compound annual growth rate of 8.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 1.08B | -13.38% |
| Dec 31, 2025 | 1.25B | -8.51% |
| Dec 31, 2024 | 1.36B | -12.69% |
| Dec 29, 2023 | 1.56B | 18.87% |
| Dec 30, 2022 | 1.31B | 50.69% |
| Dec 30, 2021 | 872.46M | 5.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| King Slide Works | 1.19T |
| Taiwan Mobile | 327.31B |
| Hotai Motor | 286.35B |
| Far Eastern New Century | 145.04B |
| Jinli Group Holdings | 1.12B |
| Redwood Group | 1.07B |
| KINGZA International CO.,Ltd. | 1.06B |
| New Palace International | 1.05B |